Anjali Joshi

Title: Anjali Joshi: Innovator in Pharmaceutical Formulations

Introduction

Anjali Joshi is a notable inventor based in Cary, NC (US). She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on compounds that target non-NMDA receptors. Her work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Anjali Joshi holds a patent for "Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds." This patent describes an aqueous pharmaceutical formulation that includes a solubilizing agent with a pyridone compound. This formulation is particularly useful as an inhibitor to non-NMDA receptors, especially the AMPA receptor. In certain embodiments, the pyridone compound is supersaturated in an aqueous solution at a pH between 6 and 8. These formulations are especially beneficial for intravenous injections.

Career Highlights

Anjali is currently employed at Eisai R&D Management Co., Ltd., where she continues to develop innovative pharmaceutical solutions. Her work has been instrumental in creating formulations that enhance the efficacy of treatments targeting specific receptors in the body.

Collaborations

Anjali collaborates with esteemed colleagues such as Geoffrey S. Hird and Ganesh S. P. Bommareddy. Their combined expertise contributes to the advancement of research and development in the pharmaceutical industry.

Conclusion

Anjali Joshi's contributions to pharmaceutical formulations exemplify her dedication to innovation in medicine. Her patent and ongoing work at Eisai R&D Management Co., Ltd. highlight her role as a key player in the field.